Arcturus Therapeutics
ARCT
#8486
Rank
โ‚ฌ0.25 B
Marketcap
8,98ย โ‚ฌ
Share price
-2.80%
Change (1 day)
18.14%
Change (1 year)

Operating Margin for Arcturus Therapeutics (ARCT)

Operating Margin as of November 2026 (TTM): -490.32%

According to Arcturus Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -490.32%. At the end of 2021 the company had an Operating Margin of -1,647.98%.

Operating Margin history for Arcturus Therapeutics from 2018 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2021-1,647.98%117.89%
2020-756.35%504.97%
2019-125.02%-9.59%
2018-138.29%64.89%
2017-83.87%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Nymox Pharmaceutical
NYMX
-234,760.00% 47,778.94% Bahamas
NRC Health
NRC
12.98%-102.65%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.